scispace - formally typeset
A

Arindom Chakraborty

Researcher at Visva-Bharati University

Publications -  33
Citations -  338

Arindom Chakraborty is an academic researcher from Visva-Bharati University. The author has contributed to research in topics: Computer science & Medicine. The author has an hindex of 8, co-authored 22 publications receiving 250 citations. Previous affiliations of Arindom Chakraborty include Central University, India & Indiana University – Purdue University Indianapolis.

Papers
More filters
Journal ArticleDOI

Genetic association of Toll-like-receptor 4 and tumor necrosis factor-α polymorphisms with Plasmodium falciparum blood infection levels

TL;DR: Dysregulated innate immune responses due to inappropriate signaling by Toll-like receptors (TLRs) and aberrant production of pro-inflammatory cytokines are implicated in the immunopathology and disease outcome in Plasmodium falciparum malaria patients and genetic role of TLR4 and TNF-alpha in controlling the blood infection level in mild malaria is supported.
Journal ArticleDOI

Increased productivity in poultry birds by sub-lethal dose of antibiotics is arbitrated by selective enrichment of gut microbiota, particularly short-chain fatty acid producers.

TL;DR: Antibiotics preferentially enrich bacterial populations, particularly short-chain fatty acid producers that can efficiently metabolize hitherto undigestable feed material such as glycans, thereby increasing the energy budget of the host and its productivity.
Journal ArticleDOI

Effect of airborne Alternaria conidia, ozone exposure, PM10 and weather on emergency visits for asthma in school-age children in Kolkata city, India

TL;DR: Airborne Alternaria conidia, ozone and PM10 in the city of Kolkata are found to have effect on school-age children with asthma and appear responsible for severe attacks leading to hospitalization.
Journal ArticleDOI

Graphic Mining of High-Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records

TL;DR: This translational bioinformatics approach yields promising results, adds valuable and complementary information to the existing pharmacovigilance literature, and has the potential to impact clinical practice.